Long term efficiency of azelastine hydrochloride and fluticasone propionate nasal spray to improve PAP adherence in patients with obstructive sleep apnea

Long term efficiency of azelastine hydrochloride and fluticasone propionate nasal spray to improve PAP adherence in patients with obstructive sleep apnea.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220517004

Enrollment

116

Registered

2022-05-17

Start date

2022-05-10

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive sleep apnea Obstructive sleep apnea PAP adherence Intranasal corticosteroid Continuous Positive Airway Pressure

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: patients aged between 18 and 75 years with newly diagnosis of OSA and passed research studies on The efficiency of azelastine hydrochloride and fluticasone propionate nasal spray to improve PAP adherence in patients with obstructive sleep apnea.- phase 1 study.

Exclusion criteria

Exclusion criteria: 1. Impair cognitive function, 2. Already used intranasal steroid, 3. Have others sleep problems such as Nacrolepsy, Insomnia, Parasomnia or Central sleep apnea. 4. Allergy to Azelastine HCl and Fluticasone proprionate, 5. Could not reading and writing

Design outcomes

Primary

Measure	Time frame
Adherence to CPAP used at 12 months after end of the intervention day of CPAP used	—

Secondary

Measure	Time frame
Nasal symptoms 12 months after use intranasal steroid TNSS score	—

Countries

Thailand

Contacts

Public ContactKasidit Wunganusorn

Faculty of medicine, internal medicine department

kasidit.wung@gmail.com0839902992

Outcome results